Rapid (90-minute) Rule-out Strategy Is Enhanced with Addition of B-type Natriuretic Peptide to Troponin I, Creatine Kinase-MB, and Myoglobin in Emergency Department Patients with Potential Acute Coronary Syndrome

2006 ◽  
Vol 13 (5Supplement 1) ◽  
pp. S159-S159
Author(s):  
A. M. Brown
Keyword(s):  
Emergency Department ◽  
Acute Coronary Syndrome ◽  
Creatine Kinase ◽  
Natriuretic Peptide ◽  
Troponin I ◽  
Coronary Syndrome ◽  
Creatine Kinase Mb ◽  
Emergency Department Patients ◽  
Rule Out

scholarly journals Utility of Ischemia Modified Albumin as an Early Marker for Diagnosis of Acute Coronary Syndrome

2018 ◽  
Vol 16 (1) ◽  
pp. 16-21 ◽  
Author(s):  
Bijaya Mishra ◽  
Sunil Pandey ◽  
Surya Raj Niraula ◽  
Bijendra Kumar Rai ◽  
Prahlad Karki ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Creatine Kinase ◽  
Diagnostic Performance ◽  
Operating Characteristic ◽  
Troponin I ◽  
Characteristic Curve ◽  
Ischemia Modified Albumin ◽  
Coronary Syndrome ◽  
Creatine Kinase Mb ◽  
St Elevation

Background: The diagnosis of acute coronary syndrome remains challenging, as cardiac troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified albumin is biomarker positive within 6-10 minutes following ischemic onset, where oxygen free radicals leads to reduction in binding capacity of human serum albumin to transitional metal-cobalt. The objective of this study was to compare ischemia modified albumin between acute coronary syndrome patients and healthy controls, and evaluate diagnostic performance of ischemia modified albumin compared to cardiac troponins, creatine kinase-MB and electrocardiogram in acute coronary syndrome patients.Methods: Fifty ACS patients and 50 healthy controls were enrolled in this cross-sectional study. Ischemia modified albumin was measured after addition of known amount of cobalt to human serum albumin, followed by spectrophotometric determination of unbound cobalt fraction at 470 nm using dithiothreitol as coloring agent. Independent student t-test and One-way ANOVA to compare differences of mean between groups; diagnostic sensitivity and specificity of ischemia modified albumin was determined by receiver operating characteristic curve; McNemar-test was used to assess diagnostic performance of entire test parameters, when used alone and in combinations.Results: Ischemia modified albumin was significantly higher in acute coronary syndrome patients compared to controls (0.823±0.191 vs 0.410±0.081)(p<0.001). Receiver operating characteristic curve derived optimal cutoff of 0.475 Absorbance unit had sensitivity and specificity of 92% and 82% respectively (area under curve- 0.96). However, no significant differences in mean ischemia modified albumin values between three categories of acute coronary syndrome were seen. Sensitivity of ischemia modified albumin assay (92%) was significantly higher compared to electrocardiogram (72%), cardiac troponin I (18%), and creatine kinase-MB(42%).Conclusions: Ischemia modified albumin is elevated in acute coronary syndrome patients with better diagnostic performance compared to electrocardiogram, cardiac troponin I, and creatine kinase-MB for early diagnosis, however, with limited ability to discriminate between ST-elevation myocardial infarction, non-ST-elevation myocardial infarction and unstable angina.

Sign in / Sign up

Export Citation Format

Share Document